UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Explore wealth management tips tailored to high income individuals, emphasizing diversified investments and efficient tax planning.
26,310 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Moderna rose to fame with COVID-19 vaccines, but the road to sustained profits is more complex. This guide breaks dow...
SpaceX is redefining its business beyond rocket launches. This article explains the spacex made huge pivot, what it c...
Ally Bank Savings remains a popular online choice for those who want a straightforward, fee-free high-yield option. T...
Gold had a remarkable run in 2025, with GLD delivering strong gains. This guide explains what happened, what it means...
In this artificial intelligence stocks march moment, savvy investors seek clarity on durable bets. This guide breaks ...
As AI investment expands across big-cap tech and startups, ACM Research and Ouster emerge as practical additions to s...
As Congress let enhanced marketplace tax credits lapse, buyers are increasingly eyeing cheaper, alternative health pl...
Casey's General Stores stock jumped after a robust earnings report that topped expectations. This guide breaks down w...
As AI accelerates, tech’s demand uninterrupted power is forcing investors to rethink NextEra Energy’s renewables-led ...
Earnings beats aren’t enough to steady markets as stocks see bigger, more persistent swings. The article explains wha...
NVIDIA posted a record quarter, sending its stock to new highs while signaling sustained AI demand. The week brought ...